2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
5.1% |
4.23% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.88% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
4.71% |
-3.48% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
5.33% |
9.26% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
5.25% |
7.64% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
4.72% |
-3.37% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
4.85% |
-0.59% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.73% |
-3.09% |
2024-10-16 |
VREX
Varex Imaging Corporation
|
Buy |
4.87% |
0% |
2024-10-18 |
NKTR
Nektar Therapeutics
|
Buy |
4.87% |
0% |
2024-10-18 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
4.87% |
0% |
2024-10-18 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
4.87% |
0% |
2024-10-18 |
The percentage of cash held in the portfolio is:
40.94%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RDNT |
Sell
All
|
-3.2% |
Assets Rebalanced
None
2024-10-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
5.04% |
3.05% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.08% |
3.9% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
4.82% |
-1.16% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.89% |
0.33% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
5.01% |
2.69% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
4.86% |
-0.33% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
4.89% |
0.2% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
4.88% |
0% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.88% |
0% |
2024-10-16 |
The percentage of cash held in the portfolio is:
55.65%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
4.95% |
0.7% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.93% |
0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
4.86% |
-0.83% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
4.9% |
0% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
4.9% |
0% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
4.9% |
0% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
4.9% |
0% |
2024-10-15 |
The percentage of cash held in the portfolio is:
65.67%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
4.92% |
0% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.9% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
4.9% |
0% |
2024-10-14 |
The percentage of cash held in the portfolio is:
85.29%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
4.86% |
-1.17% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.83% |
-1.95% |
2024-10-07 |
The percentage of cash held in the portfolio is:
90.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-6.07% |
Assets Rebalanced
None
2024-10-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
4.94% |
0.94% |
2024-10-03 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
4.9% |
0% |
2024-10-07 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.9% |
0% |
2024-10-07 |
The percentage of cash held in the portfolio is:
85.26%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
4.9% |
0% |
2024-10-03 |
The percentage of cash held in the portfolio is:
95.1%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
13.51% |
Assets Rebalanced
None
2024-09-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
5.83% |
16.82% |
2024-08-29 |
The percentage of cash held in the portfolio is:
94.17%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AADI |
Sell
All
|
8.57% |
NVCR |
Sell
All
|
-11.63% |
Assets Rebalanced
None
2024-09-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.35% |
8% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.83% |
16.92% |
2024-08-29 |
NVCR
NovoCure Limited
|
Buy |
4.38% |
-8.98% |
2024-09-06 |
The percentage of cash held in the portfolio is:
84.45%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
-1.56% |
Assets Rebalanced
None
2024-09-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.4% |
9.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.82% |
16.9% |
2024-08-29 |
NVCR
NovoCure Limited
|
Buy |
4.4% |
-8.42% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
4.75% |
-0.15% |
2024-09-09 |
The percentage of cash held in the portfolio is:
79.64%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ESPR |
Sell
All
|
-10.93% |
Assets Rebalanced
None
2024-09-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.42% |
10.29% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.73% |
15.73% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.55% |
-8.2% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
4.62% |
-3.32% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
4.85% |
2.48% |
2024-09-09 |
The percentage of cash held in the portfolio is:
74.83%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
6.76% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
5.45% |
11.15% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.26% |
7.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.65% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.74% |
-3.83% |
2024-09-02 |
NVCR
NovoCure Limited
|
Buy |
4.73% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
4.87% |
3.45% |
2024-09-09 |
The percentage of cash held in the portfolio is:
69.29%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
-2.28% |
APLS |
Sell
All
|
-8.89% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.9% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
4.98% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.07% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.56% |
10.8% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
5.09% |
1.42% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.74% |
-5.46% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.6% |
33.75% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
4.53% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
4.81% |
0.26% |
2024-09-09 |
The percentage of cash held in the portfolio is:
53.72%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.01% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.52% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.69% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.16% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.39% |
7.2% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
4.94% |
-1.71% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.67% |
-7.1% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.62% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
4.46% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
4.83% |
0.63% |
2024-09-09 |
The percentage of cash held in the portfolio is:
49.72%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.2% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.74% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.57% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.28% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.34% |
5.05% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
4.71% |
-7.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.58% |
-9.84% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.71% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
4.75% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
4.58% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
4.85% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
45.68%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.96% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.69% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.71% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.6% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.17% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.35% |
5.72% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
4.88% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.76% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.15% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
4.88% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
4.88% |
0% |
2024-09-06 |
The percentage of cash held in the portfolio is:
45.96%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.77% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.8% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.73% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.46% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.18% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.27% |
3.96% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
4.79% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.04% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.21% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
4.89% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
50.87%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.9% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.85% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.86% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.55% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
4.63% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
5.12% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
4.54% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
4.73% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.06% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
4.98% |
0% |
2024-09-04 |
The percentage of cash held in the portfolio is:
46.78%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
4.75% |
-2.98% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.78% |
-2.4% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.99% |
1.77% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.14% |
4.96% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.61% |
-5.85% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
4.65% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.06% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
4.95% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
4.89% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
4.87% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
4.93% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.93% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
41.44%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
4.76% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.72% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.1% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.11% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.6% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
4.63% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
4.73% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
4.85% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
4.96% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
4.96% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
51.58%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
4.76% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.84% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.06% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.1% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.02% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
4.75% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
4.68% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
4.91% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
60.87%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
4.72% |
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
5.3% |
6.09% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
4.78% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.82% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.17% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.21% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.18% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
4.82% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
4.82% |
0% |
2024-08-27 |
The percentage of cash held in the portfolio is:
59.89%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
4.88% |
-4.32% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
4.68% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.84% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.79% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.93% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
4.93% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
70.97%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
4.92% |
-2.95% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
4.9% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
4.9% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
4.9% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
80.38%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
4.99% |
-1.57% |
2024-07-29 |
The percentage of cash held in the portfolio is:
95.01%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
7.37% |
Assets Rebalanced
None
2024-08-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
4.74% |
7.37% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
4.82% |
-4.91% |
2024-07-29 |
The percentage of cash held in the portfolio is:
90.44%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
13.64% |
ANGO |
Sell
All
|
21.37% |
SGRY |
Sell
All
|
16.4% |
AVNS |
Sell
All
|
6.33% |
RGNX |
Sell
All
|
-8.1% |
SUPN |
Sell
All
|
12.67% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
4.38% |
-3.03% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.32% |
17.78% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.05% |
11.98% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.79% |
6.19% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.28% |
-5.27% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
5.06% |
12.04% |
2024-07-12 |
RCM
R1 RCM Inc.
|
Buy |
4.78% |
7.14% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
4.74% |
-7.66% |
2024-07-29 |
The percentage of cash held in the portfolio is:
61.6%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
1.39% |
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
4.48% |
-0.76% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.5% |
22.02% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.07% |
12.41% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.88% |
8.36% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.44% |
-1.57% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.42% |
-2% |
2024-07-12 |
RCM
R1 RCM Inc.
|
Buy |
4.77% |
7.06% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
4.85% |
-5.3% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
4.77% |
3.67% |
2024-07-31 |
The percentage of cash held in the portfolio is:
56.83%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PDSB |
Sell
All
|
-10.51% |
MASI |
Sell
All
|
-6.4% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.07% |
-8.52% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.55% |
2.27% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.63% |
26.75% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.05% |
13.78% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
5.03% |
13.36% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.56% |
2.6% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.49% |
1.02% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.19% |
-5.02% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.73% |
7.83% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
4.95% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
4.88% |
7.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
47.89%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CUTR |
Sell
All
|
-19.59% |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.1% |
-8.24% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.67% |
4.55% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.68% |
27.08% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.28% |
18.28% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
5.01% |
12.13% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
3.92% |
-12.16% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.68% |
4.72% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.64% |
3.79% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.25% |
-4.14% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.79% |
8.44% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
5% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
4.88% |
-3.84% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
8% |
57.44% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.51% |
-11.19% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
4.21% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
4.71% |
3.13% |
2024-07-31 |
The percentage of cash held in the portfolio is:
21.66%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FATE |
Sell
All
|
-12.39% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.45% |
1.14% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.73% |
7.58% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.62% |
27.9% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.22% |
18.83% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.96% |
12.94% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.15% |
-5.41% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.92% |
12.12% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.6% |
4.67% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.17% |
-4.45% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.29% |
-1.15% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.1% |
-4.31% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
5.16% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
4.84% |
-3.09% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
7.44% |
48.93% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.97% |
-0.36% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
4.25% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
4.6% |
2.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
17.54%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
27.55% |
RYTM |
Sell
All
|
12.98% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.95% |
26.42% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.26% |
11.69% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.41% |
-1.7% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.86% |
8.33% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.73% |
27.73% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.48% |
22.27% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.86% |
8.4% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.36% |
-2.7% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
5.04% |
12.43% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.76% |
6.28% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.23% |
-4.93% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.39% |
-1% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.03% |
-7.9% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
5.17% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
4.94% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
6% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
5.01% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
4.37% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
4.58% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
6.58%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.07% |
30.89% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.29% |
14.23% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.79% |
8.52% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.78% |
8.33% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.51% |
24.96% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.37% |
21.76% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.76% |
8.03% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.17% |
-5.41% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.98% |
12.9% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.73% |
7.37% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.23% |
-3.46% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.25% |
-2.61% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.18% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
4.8% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
4.74% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
5.1% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
4.93% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
6.06% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.93% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
4.32% |
0% |
2024-07-30 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.81% |
26.12% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.3% |
14.95% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.84% |
10.23% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.92% |
12.12% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.47% |
24.8% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.5% |
25.32% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.79% |
9.25% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.5% |
2.7% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.94% |
12.75% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.73% |
7.93% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.24% |
-2.65% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.33% |
-0.19% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.18% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
4.45% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
5.07% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
4.99% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
4.99% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
4.99% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
4.99% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.99% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.75% |
23.69% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.4% |
16.26% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.96% |
11.93% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.76% |
7.58% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.42% |
22.51% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.32% |
20.35% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.79% |
8.22% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.18% |
-5.41% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
5.01% |
13.22% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.76% |
7.69% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.31% |
-1.95% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.33% |
-0.84% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.18% |
-3.05% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
4.63% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
5.03% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
27.16%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
48.75% |
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.4% |
35.31% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.66% |
19.76% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.46% |
15.58% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.82% |
6.96% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.85% |
7.58% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.38% |
19.58% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.23% |
16.16% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.8% |
6.7% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.38% |
-2.7% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.83% |
7.32% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.81% |
6.84% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.36% |
-2.4% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.49% |
0.92% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.08% |
-7% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
4.74% |
0% |
2024-07-25 |
The percentage of cash held in the portfolio is:
25.72%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ACAD |
Sell
All
|
16.37% |
EGRX |
Sell
All
|
20.09% |
SAGE |
Sell
All
|
-11.55% |
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.34% |
14.55% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.01% |
28.79% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
5.86% |
26.56% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.47% |
18.17% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.4% |
16.71% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.3% |
20.17% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.81% |
9.09% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.37% |
22.02% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
4.88% |
10.92% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.72% |
7.18% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.7% |
6.76% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.68% |
6.22% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.91% |
11.46% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.62% |
4.95% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.28% |
-2.07% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.49% |
3.07% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
4.29% |
0% |
2024-07-24 |
The percentage of cash held in the portfolio is:
14.88%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.32% |
11.78% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.24% |
31.03% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
5.57% |
17.81% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.17% |
9.54% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.49% |
16.17% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.95% |
9.94% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
5.08% |
12.88% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.27% |
17.13% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.11% |
13.7% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.67% |
3.82% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.83% |
7.43% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.45% |
-1.02% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.71% |
4.73% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.77% |
6.18% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.26% |
-4.64% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.53% |
2% |
2024-07-18 |
The percentage of cash held in the portfolio is:
19.58%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TDOC |
Sell
All
|
-2.99% |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.41% |
13.35% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.13% |
28.57% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
5.57% |
17.81% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.18% |
9.54% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.46% |
15.44% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.94% |
9.66% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
3.95% |
-12.43% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
5.19% |
15.15% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.11% |
13.38% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
4.47% |
-0.64% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.13% |
13.89% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.77% |
5.95% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.72% |
4.73% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.55% |
1.1% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.67% |
3.71% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.6% |
2.14% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.29% |
-4.06% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.39% |
-1.46% |
2024-07-18 |
The percentage of cash held in the portfolio is:
11.46%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
7.35% |
WST |
Sell
All
|
-5.09% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.34% |
15.55% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.17% |
33.48% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.09% |
10.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.64% |
23.12% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
5.29% |
15.37% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.59% |
22.05% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.97% |
13.92% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
4.37% |
0.13% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.69% |
7.58% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.28% |
-1.88% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.26% |
20.72% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
4.67% |
7.04% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
5.04% |
15.66% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.66% |
6.89% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.92% |
12.84% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.56% |
4.48% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.51% |
3.54% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.43% |
1.61% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.22% |
-2.67% |
2024-07-15 |
RCM
R1 RCM Inc.
|
Buy |
4.31% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
Assets Rebalanced
None
2024-07-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.35% |
11.9% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.43% |
34.37% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.42% |
13.27% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.63% |
18.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.99% |
5.15% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.56% |
17.23% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.25% |
16.19% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
4.76% |
5.28% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
4.77% |
5.61% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.72% |
4.55% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.37% |
-3.1% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
4.42% |
-2.12% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
4.52% |
0.21% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
4.75% |
5.17% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.49% |
-0.47% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.48% |
-0.68% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.54% |
0.47% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.52% |
0.21% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.53% |
0.46% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
4.48% |
0% |
2024-07-15 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.4% |
11.15% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.54% |
34.6% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.35% |
10.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.58% |
15.94% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.72% |
-1.97% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.26% |
9.21% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
5.06% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
4.81% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
4.71% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.76% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
4.58% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
6.58%
New Assets Added
- WST
- ANGO
- TDOC
- SGRY
- AVNS
- CUTR
- RGNX
- SAGE
- SUPN
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.36% |
7.75% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.71% |
34.82% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.3% |
6.55% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.15% |
4.37% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.58% |
-7.12% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.13% |
4.01% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
4.7% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
4.7% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
4.7% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
4.7% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
48.98%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.36% |
7.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.73% |
35.49% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.27% |
6.02% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.11% |
3.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.6% |
-6.59% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.19% |
5.32% |
2024-07-02 |
The percentage of cash held in the portfolio is:
67.73%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Sell
All
|
-11.61% |
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.12% |
2.77% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.68% |
34.15% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.19% |
4.12% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5% |
1.25% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
4.8% |
-2.79% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.6% |
-6.81% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.07% |
2.55% |
2024-07-02 |
The percentage of cash held in the portfolio is:
63.53%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VERU |
Sell
All
|
-3.41% |
Assets Rebalanced
None
2024-07-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.93% |
-1.83% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.16% |
22.77% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.07% |
0.9% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.24% |
5.31% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
4.85% |
-2.67% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.62% |
-7.27% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.76% |
-4.36% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
5.15% |
3.41% |
2024-07-02 |
The percentage of cash held in the portfolio is:
59.22%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
1.87% |
Assets Rebalanced
None
2024-07-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.98% |
-0.25% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.83% |
16.74% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
5.26% |
5.2% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.14% |
2.79% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.31% |
7.19% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
4.81% |
-3.02% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.56% |
-7.95% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.92% |
-0.77% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
5.35% |
7.95% |
2024-07-02 |
The percentage of cash held in the portfolio is:
53.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CHRS |
Sell
All
|
-19.65% |
MNKD |
Sell
All
|
-7.37% |
ARDX |
Sell
All
|
-28.74% |
Assets Rebalanced
None
2024-07-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.9% |
1.01% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
4.55% |
-6.26% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.99% |
23.44% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
5.44% |
12.05% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.01% |
3.19% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
4.99% |
3.75% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
4.91% |
2.16% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
4.48% |
-6.94% |
2024-07-01 |
NVRO
Nevro Corp.
|
Buy |
4.81% |
0% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
4.81% |
0% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.81% |
0% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
4.81% |
0% |
2024-07-02 |
The percentage of cash held in the portfolio is:
40.49%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.94% |
2.33% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
4.64% |
-3.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.03% |
25% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
5.43% |
12.5% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
4.98% |
3.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
5.02% |
5% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
4.78% |
0% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
4.78% |
0% |
2024-07-01 |
The percentage of cash held in the portfolio is:
59.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.01% |
3.09% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
4.74% |
-2.58% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.45% |
12.05% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
5.38% |
10.52% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
5.06% |
3.94% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
4.82% |
0% |
2024-06-28 |
The percentage of cash held in the portfolio is:
69.54%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.78% |
-2.39% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
4.68% |
-4.42% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.38% |
9.82% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
5.27% |
7.54% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
4.98% |
1.71% |
2024-06-26 |
The percentage of cash held in the portfolio is:
74.9%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Sell
All
|
-12.08% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.83% |
-1.76% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
4.74% |
-3.5% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
4.79% |
-2.5% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
4.99% |
1.56% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
4.92% |
0% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
4.92% |
0% |
2024-06-26 |
The percentage of cash held in the portfolio is:
70.81%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
4.9% |
0% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
4.9% |
0% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
4.9% |
0% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
4.9% |
0% |
2024-06-25 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-17 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
0.32% |
Assets Rebalanced
None
2024-06-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
4.49% |
-0.72% |
2024-05-16 |
The percentage of cash held in the portfolio is:
95.51%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Sell
All
|
-6.02% |
Assets Rebalanced
None
2024-06-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.77% |
1% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.6% |
2.24% |
2024-05-16 |
The percentage of cash held in the portfolio is:
90.63%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EDIT |
Sell
All
|
-4.9% |
Assets Rebalanced
None
2024-06-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.91% |
4.26% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.62% |
-1.93% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.58% |
2% |
2024-05-16 |
The percentage of cash held in the portfolio is:
85.9%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ABUS |
Sell
All
|
29.64% |
Assets Rebalanced
None
2024-06-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.84% |
19.29% |
2024-05-07 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.88% |
3.26% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.76% |
0.7% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.6% |
2.16% |
2024-05-16 |
The percentage of cash held in the portfolio is:
79.91%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OMCL |
Sell
All
|
1.76% |
AORT |
Sell
All
|
11.42% |
Assets Rebalanced
None
2024-06-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
5.29% |
8.16% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.52% |
12.76% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.88% |
20% |
2024-05-07 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.81% |
1.75% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.31% |
-8.93% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.64% |
2.88% |
2024-05-16 |
The percentage of cash held in the portfolio is:
69.54%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
INGN |
Sell
All
|
17.73% |
GKOS |
Sell
All
|
7.32% |
KIDS |
Sell
All
|
-0.72% |
ALT |
Sell
All
|
4.45% |
Assets Rebalanced
None
2024-05-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Buy |
5.55% |
14.89% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
5.07% |
5.06% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.93% |
2.07% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.6% |
-4.73% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
5.22% |
5.58% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.61% |
13.47% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.94% |
20% |
2024-05-07 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.66% |
-2.51% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.27% |
-10.68% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.69% |
3.04% |
2024-05-16 |
The percentage of cash held in the portfolio is:
49.47%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGMO |
Sell
All
|
5.56% |
Assets Rebalanced
None
2024-05-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Buy |
5.81% |
21.99% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.47% |
14.81% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.96% |
4.07% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.07% |
6.35% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.62% |
-3.06% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
5.24% |
7.53% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.46% |
12.04% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.84% |
19.64% |
2024-05-07 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.8% |
2.01% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.39% |
-6.83% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.58% |
2% |
2024-05-16 |
The percentage of cash held in the portfolio is:
43.76%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Sell
All
|
3.27% |
Assets Rebalanced
None
2024-05-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Buy |
5.93% |
24.96% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.27% |
11.11% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.92% |
3.68% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.85% |
2.29% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.84% |
1.95% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
5.26% |
8.3% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.33% |
9.74% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.51% |
13.62% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.71% |
17.5% |
2024-05-07 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.7% |
0.25% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.63% |
-1.4% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.47% |
-0.16% |
2024-05-16 |
The percentage of cash held in the portfolio is:
38.58%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-11.24% |
SENS |
Sell
All
|
-8.83% |
Assets Rebalanced
None
2024-05-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.63% |
-2.91% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.39% |
-7.8% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.55% |
17.02% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.44% |
14.81% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.85% |
2.29% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.73% |
-0.25% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.87% |
2.78% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
5.1% |
5.21% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.28% |
8.86% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.48% |
13% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.69% |
17.14% |
2024-05-07 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.9% |
4.51% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.79% |
2.1% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.34% |
-2.92% |
2024-05-16 |
The percentage of cash held in the portfolio is:
29.97%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VCYT |
Sell
All
|
-7.38% |
Assets Rebalanced
None
2024-05-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.74% |
1.85% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.55% |
-2.26% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.67% |
22.55% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.49% |
18.52% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.75% |
2.57% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.82% |
4.21% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
5.08% |
9.74% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
5.06% |
7% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.08% |
7.38% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.37% |
13.52% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.77% |
21.79% |
2024-05-07 |
VCYT
Veracyte, Inc.
|
Buy |
4.4% |
-3.91% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
5.16% |
12.78% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.82% |
5.43% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.24% |
-2.72% |
2024-05-16 |
The percentage of cash held in the portfolio is:
25.01%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
-2.32% |
ACRS |
Sell
All
|
-8.73% |
Assets Rebalanced
None
2024-05-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.67% |
-0.79% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.53% |
-3.7% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.82% |
24.26% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.43% |
-5.56% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.29% |
12.96% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.87% |
4.04% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.79% |
2.26% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
5.24% |
11.82% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.89% |
1.99% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.09% |
6.21% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.45% |
13.76% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.26% |
9.64% |
2024-05-07 |
VCYT
Veracyte, Inc.
|
Buy |
4.59% |
-0.89% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
5.14% |
11.03% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.48% |
-3.33% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.32% |
-2.08% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
4.19% |
-0.67% |
2024-05-17 |
The percentage of cash held in the portfolio is:
16.93%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PTCT |
Sell
All
|
40.43% |
Assets Rebalanced
None
2024-05-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.49% |
15.84% |
2024-04-29 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.7% |
-0.79% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.72% |
-0.41% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.9% |
25.25% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.45% |
-5.56% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.67% |
20.37% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.93% |
4.53% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.74% |
0.66% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
5.25% |
11.4% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.87% |
1.03% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.05% |
4.74% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.4% |
12.09% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.14% |
6.43% |
2024-05-07 |
VCYT
Veracyte, Inc.
|
Buy |
4.74% |
1.69% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
5.31% |
14.04% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.58% |
-1.58% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.42% |
-0.56% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
4.29% |
1.02% |
2024-05-17 |
The percentage of cash held in the portfolio is:
10.38%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
IBRX |
Sell
All
|
-14.91% |
RYTM |
Sell
All
|
-8.38% |
Assets Rebalanced
None
2024-05-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.56% |
19.11% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.02% |
-13.79% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.97% |
6.48% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.72% |
1.03% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.9% |
26.95% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.35% |
-6.35% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.25% |
12.96% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.39% |
-5.45% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.88% |
5.12% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.64% |
-0.06% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
5.75% |
23.78% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.99% |
5.08% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.15% |
8.41% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.33% |
12.28% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
4.91% |
3.21% |
2024-05-07 |
VCYT
Veracyte, Inc.
|
Buy |
4.78% |
4% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
5.18% |
12.78% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.74% |
3.15% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.31% |
-1.52% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
4.18% |
0% |
2024-05-17 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MD |
Sell
All
|
-8.68% |
Assets Rebalanced
None
2024-05-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.53% |
17.82% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.23% |
-9.9% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.72% |
0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.78% |
1.85% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.86% |
25.39% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.37% |
-6.35% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.02% |
7.41% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.46% |
-4.42% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.95% |
6.06% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.61% |
-1.38% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
5.76% |
23.37% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.73% |
-0.86% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.04% |
5.62% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.41% |
13.38% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
4.8% |
0.36% |
2024-05-07 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
4.44% |
-3.87% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
4.83% |
4.67% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
5.2% |
12.53% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.85% |
5.08% |
2024-05-14 |
RCM
R1 RCM Inc.
|
Buy |
4.4% |
0% |
2024-05-16 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
WST |
Sell
All
|
-4.6% |
Assets Rebalanced
None
2024-05-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.35% |
10.96% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.63% |
-4% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.78% |
-0.79% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.4% |
-8.83% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
6% |
25.04% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.5% |
-6.35% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.89% |
1.85% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.66% |
-2.97% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.95% |
3.17% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.67% |
-2.79% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.7% |
-2.14% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.92% |
2.5% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
5.02% |
2.22% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
5.05% |
2.82% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.44% |
10.85% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.07% |
3.21% |
2024-05-07 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
4.74% |
0% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
4.74% |
0% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
4.74% |
0% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
4.74% |
0% |
2024-05-14 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.5% |
12.88% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.4% |
-9.68% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.61% |
-5.29% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.66% |
-4.31% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.82% |
20% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.5% |
-7.14% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
5.03% |
3.7% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.58% |
-5.53% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
5.1% |
5.17% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.79% |
-1.16% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.74% |
-2.26% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.87% |
0.42% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.95% |
-0.03% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
4.6% |
-7.18% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.57% |
12.42% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.1% |
2.86% |
2024-05-07 |
The percentage of cash held in the portfolio is:
21.18%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
IOVA |
Sell
All
|
-12.24% |
Assets Rebalanced
None
2024-05-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.19% |
8.68% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.28% |
-10.34% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.8% |
0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.72% |
-1.23% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.86% |
23.26% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.62% |
-2.78% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
5.11% |
7.6% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.58% |
-3.7% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.42% |
-7.07% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.87% |
2.47% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.71% |
-0.78% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5% |
5.28% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
5.1% |
7.37% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.88% |
0.4% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
4.72% |
-2.91% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.43% |
11.8% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.11% |
5% |
2024-05-07 |
The percentage of cash held in the portfolio is:
16.6%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Sell
All
|
7.67% |
Assets Rebalanced
None
2024-05-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.28% |
9% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.26% |
-11.9% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
5.37% |
10.85% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.69% |
-3.04% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.73% |
-2.26% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
5.63% |
16.88% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.67% |
-3.17% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
5.16% |
7.12% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.46% |
-7.41% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.53% |
-6.06% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.9% |
1.79% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.79% |
-0.49% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.03% |
4.31% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.8% |
-0.42% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.9% |
-0.56% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
4.69% |
-4.82% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
5.48% |
11.32% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5% |
1.43% |
2024-05-07 |
The percentage of cash held in the portfolio is:
11.62%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BLUE |
Sell
All
|
-3% |
PEN |
Sell
All
|
-2.62% |
Assets Rebalanced
None
2024-05-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.5% |
15.37% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.14% |
-13.13% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
5.31% |
11.38% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.98% |
4.5% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.93% |
3.49% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
4.84% |
1.99% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.93% |
3.97% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
5.26% |
11.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.65% |
-1.85% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
5.02% |
5.91% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.74% |
-0.02% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.72% |
-0.52% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.01% |
5.63% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.85% |
2.36% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.82% |
-0.5% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
4.8% |
-1% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
4.88% |
0.67% |
2024-05-06 |
PEN
Penumbra, Inc.
|
Buy |
4.92% |
1.47% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
4.85% |
0% |
2024-05-07 |
BLUE
bluebird bio, Inc.
|
Buy |
4.85% |
0% |
2024-05-07 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.47% |
15.54% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.82% |
1.78% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
5.16% |
9.13% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.87% |
2.94% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.91% |
3.68% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
4.78% |
1.42% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.08% |
7.94% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
5.13% |
9.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.85% |
2.93% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.97% |
5.62% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.77% |
1.41% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.66% |
-0.93% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.86% |
3.21% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.78% |
1.53% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
4.81% |
0% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
4.81% |
0% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
4.81% |
0% |
2024-05-06 |
PEN
Penumbra, Inc.
|
Buy |
4.81% |
0% |
2024-05-06 |
The percentage of cash held in the portfolio is:
11.63%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMMT |
Sell
All
|
13.73% |
Assets Rebalanced
None
2024-05-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.67% |
17.68% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
5.07% |
5.18% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.81% |
-0.22% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
5.22% |
8.47% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.92% |
2.12% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
5.12% |
6.37% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
4.78% |
-0.28% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.98% |
3.97% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
4.94% |
3.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.62% |
-3.7% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.74% |
-1.09% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
4.79% |
0% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
4.79% |
0% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.79% |
0% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
4.79% |
0% |
2024-05-03 |
The percentage of cash held in the portfolio is:
25.96%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.78% |
19.57% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
5.89% |
21.76% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.59% |
-5.01% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
4.91% |
1.46% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.85% |
0.4% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.6% |
-4.93% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
4.81% |
0% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.81% |
0% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
4.81% |
0% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
4.81% |
0% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
4.81% |
0% |
2024-05-02 |
The percentage of cash held in the portfolio is:
45.32%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
-3.05% |
Assets Rebalanced
None
2024-05-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
4.44% |
-6.87% |
2024-04-02 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.53% |
12.53% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
5% |
1.81% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.37% |
-11.12% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
4.96% |
0.93% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.89% |
-0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
4.92% |
0% |
2024-05-01 |
The percentage of cash held in the portfolio is:
65.9%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
4.49% |
-5.34% |
2024-04-02 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
5.5% |
12.5% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
4.91% |
0.52% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
4.89% |
0% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
4.89% |
0% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
4.89% |
0% |
2024-04-30 |
The percentage of cash held in the portfolio is:
70.43%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
4.59% |
-3.82% |
2024-04-02 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
4.92% |
0% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
4.92% |
0% |
2024-04-29 |
The percentage of cash held in the portfolio is:
85.58%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Sell
All
|
1.93% |
KIDS |
Sell
All
|
4.45% |
ACRS |
Sell
All
|
-4.76% |
Assets Rebalanced
None
2024-04-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
5.38% |
10.7% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.11% |
5.11% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.67% |
-3.97% |
2024-03-28 |
OPK
OPKO Health, Inc.
|
Buy |
4.46% |
-6.11% |
2024-04-02 |
The percentage of cash held in the portfolio is:
80.37%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TNDM |
Sell
All
|
-9.75% |
Assets Rebalanced
None
2024-04-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
5.42% |
11.75% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.6% |
-5.1% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.2% |
7.32% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.65% |
-3.97% |
2024-03-28 |
OPK
OPKO Health, Inc.
|
Buy |
4.44% |
-6.11% |
2024-04-02 |
The percentage of cash held in the portfolio is:
75.69%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RVNC |
Sell
All
|
-16.06% |
Assets Rebalanced
None
2024-04-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
5.77% |
20.18% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.7% |
-2.07% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.27% |
9.67% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.42% |
-7.94% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
4.3% |
-10.37% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
4.55% |
-3.05% |
2024-04-02 |
The percentage of cash held in the portfolio is:
70.99%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Sell
All
|
-15.83% |
Assets Rebalanced
None
2024-04-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
5.94% |
23.33% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.59% |
-4.65% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.56% |
-5.18% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.54% |
-5.56% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
4.31% |
-10.37% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
4.13% |
-14.17% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
4.84% |
3.05% |
2024-04-02 |
The percentage of cash held in the portfolio is:
67.08%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BAX |
Sell
All
|
-0.86% |
ADMA |
Sell
All
|
4.41% |
Assets Rebalanced
None
2024-04-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BAX
Baxter International Inc.
|
Buy |
5.36% |
-0.19% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.65% |
5.23% |
2024-03-07 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.24% |
8.6% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.58% |
-5.1% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.44% |
-7.9% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.67% |
-3.17% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
4.42% |
-8.33% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
4.44% |
-7.92% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
4.85% |
3.05% |
2024-04-02 |
The percentage of cash held in the portfolio is:
56.34%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OMCL |
Sell
All
|
-0.14% |
VCYT |
Sell
All
|
-5.57% |
THC |
Sell
All
|
9.07% |
RDNT |
Sell
All
|
8.23% |
NTRA |
Sell
All
|
2.8% |
BHVN |
Sell
All
|
-9.93% |
Assets Rebalanced
None
2024-04-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
5.71% |
10.71% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
5.59% |
8.48% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
5.36% |
3.97% |
2024-03-04 |
BHVN
Biohaven Ltd.
|
Buy |
4.2% |
-7.68% |
2024-03-05 |
BAX
Baxter International Inc.
|
Buy |
5.37% |
1.3% |
2024-03-07 |
OMCL
Omnicell, Inc.
|
Buy |
5.46% |
3.02% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.67% |
6.86% |
2024-03-07 |
ANGO
AngioDynamics, Inc.
|
Buy |
4.88% |
2.28% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.57% |
-4.11% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.64% |
-2.69% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.77% |
0% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
4.75% |
-0.37% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
4.58% |
-3.86% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
4.53% |
-5% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
4.65% |
0% |
2024-04-02 |
The percentage of cash held in the portfolio is:
25.27%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OFIX |
Sell
All
|
-3.17% |
ATRI |
Sell
All
|
-11.81% |
Assets Rebalanced
None
2024-03-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
5.64% |
11.48% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
5.55% |
9.72% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
5.17% |
2.29% |
2024-03-04 |
BHVN
Biohaven Ltd.
|
Buy |
4.33% |
-3.01% |
2024-03-05 |
BAX
Baxter International Inc.
|
Buy |
5.17% |
-0.58% |
2024-03-07 |
OMCL
Omnicell, Inc.
|
Buy |
5.47% |
5.18% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.61% |
7.84% |
2024-03-07 |
ANGO
AngioDynamics, Inc.
|
Buy |
4.82% |
2.98% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.69% |
0.31% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.71% |
0.66% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.61% |
-1.59% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
4.77% |
2.03% |
2024-03-28 |
ATRI
Atrion Corporation
|
Buy |
4.68% |
0% |
2024-03-29 |
OFIX
Orthofix Medical Inc.
|
Buy |
4.68% |
0% |
2024-03-29 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
4.68% |
0% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
4.68% |
0% |
2024-03-29 |
The percentage of cash held in the portfolio is:
20.72%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
5.63% |
11.22% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
5.53% |
9.33% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
5.12% |
1.17% |
2024-03-04 |
BHVN
Biohaven Ltd.
|
Buy |
4.52% |
1.12% |
2024-03-05 |
BAX
Baxter International Inc.
|
Buy |
5.17% |
-0.7% |
2024-03-07 |
OMCL
Omnicell, Inc.
|
Buy |
5.48% |
5.22% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.73% |
10.13% |
2024-03-07 |
ANGO
AngioDynamics, Inc.
|
Buy |
4.68% |
0% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
4.68% |
0% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
4.68% |
0% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
4.68% |
0% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
4.68% |
0% |
2024-03-28 |
The percentage of cash held in the portfolio is:
39.44%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
5.54% |
8.8% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
5.42% |
6.45% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
5.29% |
3.9% |
2024-03-04 |
BHVN
Biohaven Ltd.
|
Buy |
4.73% |
5.27% |
2024-03-05 |
BAX
Baxter International Inc.
|
Buy |
5.1% |
-2.7% |
2024-03-07 |
OMCL
Omnicell, Inc.
|
Buy |
5.27% |
0.5% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.41% |
3.27% |
2024-03-07 |
The percentage of cash held in the portfolio is:
63.24%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
QTRX |
Sell
All
|
-9.55% |
Assets Rebalanced
None
2024-03-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
5.48% |
6.46% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
5.2% |
1.08% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
5.18% |
0.79% |
2024-03-04 |
QTRX
Quanterix Corporation
|
Buy |
4.3% |
-5.31% |
2024-03-05 |
BHVN
Biohaven Ltd.
|
Buy |
4.57% |
0.62% |
2024-03-05 |
BAX
Baxter International Inc.
|
Buy |
5.11% |
-3.37% |
2024-03-07 |
OMCL
Omnicell, Inc.
|
Buy |
5.23% |
-1.15% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.14% |
-2.94% |
2024-03-07 |
The percentage of cash held in the portfolio is:
59.78%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ABUS |
Sell
All
|
-5.93% |
Assets Rebalanced
None
2024-03-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
5.38% |
4.78% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
5.15% |
0.23% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
5.14% |
0.12% |
2024-03-04 |
QTRX
Quanterix Corporation
|
Buy |
4.29% |
-5.42% |
2024-03-05 |
BHVN
Biohaven Ltd.
|
Buy |
4.59% |
1.21% |
2024-03-05 |
BAX
Baxter International Inc.
|
Buy |
5.12% |
-3.21% |
2024-03-07 |
OMCL
Omnicell, Inc.
|
Buy |
5.27% |
-0.36% |
2024-03-07 |
ADMA
ADMA Biologics, Inc.
|
Buy |
5.17% |
-2.12% |
2024-03-07 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
5.16% |
-2.96% |
2024-03-08 |
The percentage of cash held in the portfolio is:
54.71%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BRKR |
Sell
All
|
15.05% |
RCM |
Sell
All
|
21.04% |
MTD |
Sell
All
|
11.05% |
Assets Rebalanced
None